Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaekyung Cheon

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Liver Cancer|October 21, 2020
Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective AnalysisJaekyung Cheon, Hong Jae Chon, Yeonghak Bang, et al.
Liver Cancer|August 20, 2025
Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus BevacizumabJaekyung Cheon, Baek-Yeol Ryoo, Hong Jae Chon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2024
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective studyJaekyung Cheon, Sanghoon Jung, Jung Sun Kim, et al.
Targeted Oncology|October 3, 2024
Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-PacificSejin Kim, Suat Ying Lee, Jaekyung Cheon, et al.
Journal for Immunotherapy of Cancer|October 21, 2021
High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancerHyung Soon Park, Yoo Min Kim, Sewha Kim, et al.
Therapeutic Advances in Medical Oncology|June 12, 2020
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysisHeejung Chae, Hyehyun Jeong, Jaekyung Cheon, et al.
BMC Palliative Care|April 28, 2021
Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making actHyeyeong Kim, Hyeon-Su Im, Kyong Og Lee, et al.
BMC Cancer|April 8, 2020
CD45<sup>dim</sup>CD34<sup>+</sup>CD38<sup>-</sup>CD133<sup>+</sup> cells have the potential as leukemic stem cells in acute myeloid leukemiaSook-Kyoung Heo, Eui-Kyu Noh, Lan Jeong Ju, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 16, 2018
Rhein augments ATRA-induced differentiation of acute promyelocytic leukemia cellsSook-Kyoung Heo, Eui-Kyu Noh, Jeong Yi Kim, et al.
American Journal of Cancer Research|April 6, 2019
The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205Seyoung Seo, Yongwha Moon, Junyoung Choi, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Liver Cancer|October 21, 2020
Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective AnalysisJaekyung Cheon, Hong Jae Chon, Yeonghak Bang, et al.
Liver Cancer|August 20, 2025
Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus BevacizumabJaekyung Cheon, Baek-Yeol Ryoo, Hong Jae Chon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2024
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective studyJaekyung Cheon, Sanghoon Jung, Jung Sun Kim, et al.
Targeted Oncology|October 3, 2024
Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-PacificSejin Kim, Suat Ying Lee, Jaekyung Cheon, et al.
Journal for Immunotherapy of Cancer|October 21, 2021
High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancerHyung Soon Park, Yoo Min Kim, Sewha Kim, et al.
Therapeutic Advances in Medical Oncology|June 12, 2020
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysisHeejung Chae, Hyehyun Jeong, Jaekyung Cheon, et al.
BMC Palliative Care|April 28, 2021
Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making actHyeyeong Kim, Hyeon-Su Im, Kyong Og Lee, et al.
BMC Cancer|April 8, 2020
CD45<sup>dim</sup>CD34<sup>+</sup>CD38<sup>-</sup>CD133<sup>+</sup> cells have the potential as leukemic stem cells in acute myeloid leukemiaSook-Kyoung Heo, Eui-Kyu Noh, Lan Jeong Ju, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 16, 2018
Rhein augments ATRA-induced differentiation of acute promyelocytic leukemia cellsSook-Kyoung Heo, Eui-Kyu Noh, Jeong Yi Kim, et al.
American Journal of Cancer Research|April 6, 2019
The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205Seyoung Seo, Yongwha Moon, Junyoung Choi, et al.
Pageof 10